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Abstract Clinically, gout is generally considered as a
preferential male disease. However, it definitely does not
occur exclusively in males. Our aim was to assess differences
in the clinical features of gout arthritis between female and
male patients. Five electronic databases were searched to
identify relevant original studies published between 1977 and
2007. The included studies had to focus on adult patients with
primary gout arthritis and on sex differences in clinical
features. Two reviewers independently assessed eligibility
and quality of the studies. Out of 355 articles, 14 were
selected. Nine fulfilled the quality and score criteria. We
identified the following sex differences in the clinical features
of gout in women compared to men: the onset of gout occurs
at a higher age, more comorbidity with hypertension or renal
insufficiency, more often use of diuretics, less likely to drink
alcohol, less often podagra but more often involvement of
other joints, less frequent recurrent attacks. We found
interesting sex differences regarding the clinical features of
patients with gout arthritis. To diagnose gout in women,
knowledge of these differences isessential, and more research
is needed to understand and explain the differences ,
especially in the general population.
Keywords Female.Gender.Gout.Sexcharacteristics.Sex
differences
Introduction
Gout is a frequent form of arthritis, presenting as a severe
and painful inflammatory arthritis, mostly of the first
metatarsophalangeal joint (podagra). It occurs suddenly,
and in most patients it disappears completely within 5 to
14 days [1].
Gout affects around 1% of adult men in Western
countries, mostly aged over 45 years. The estimated
incidence of gout in these countries is 0.6 to 2.1 per
1,000 per year, with a prevalence of 3 to 7.5 per 1,000 per
year [2–4]. Accumulating data support an increase in the
prevalence of gout that is potentially attributable to recent
shifts in diet, lifestyle, medical care, and increased
longevity. The increased longevity of the population in
industrialized countries may contribute to a higher preva-
lence of gout through the disorder’s association with age-
related diseases such as hypertension and cardiovascular
diseases. The increasing prevalence of gout worldwide
indicates a need for improved effort to identify these
patients early in the disease process [5].
Clinically, gout is often considered a preferential male
disease. The condition is more common in men than in
women. In women, it mainly becomes manifest in the
postmenopausal period. Hippocrates was the first who
stated that it was a sex-related disease. Among patients
younger than 65 years, men have a fourfold greater
prevalence than women [6]. However, the incidence of
gout in the elderly has a more equal sex distribution. The
impact of female hormones cannot be neglected because
estradiol can lower serum urate in females, and the serum
urate rises after the menopause [7]. In patients older than
65 years, the sex gap narrows to one woman to every three
men with gout and/or hyperuricemia [5]. Research about
gout arthritis in the general population is rare; even less is
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The aim of this review is to evaluate the available studies
on the sex differences in clinical features of gout arthritis.
Therefore, our research question was: What is known in
medical literature about the clinical features of gout in
females compared to males?
Methods
The present review was conducted in cooperation with a
trained librarian (EP), according to the methodology of the
Effective Practice and Organization of Care module from
the Cochrane library [8]. Electronic searches were under-
taken in MEDLINE, EMBASE, the Cochrane Clinical
Trials Register, and Web of Science. The search strategy
aimed to identify original relevant research papers pub-
lished between 1977 and 2007 on gout and sex differences.
It consisted of the AND combination of two main concepts:
gout and the gender-specific filter . Meaning: Gout AND
sex characteristics OR sex distribution OR sex factors OR
sex differences OR gender identity OR gender OR sex
distribution OR women’s health OR menopause OR
pregnancy OR breast feeding OR menstruation OR gonadal
hormones OR men’s health—in Mesh headings and text
words [9].
T h es t r a t e g yu s e dt oi d e n t i f yr e l e v a n ta r t i c l e sw a s
adapted to the specific search criteria required for each
database. Hyperuricemia can be present in a patient who
does not have acute gout arthritis, and a patient, however
seldom, can have gout without hyperuricemia. For this
reason, we left the term hyperuricemia out of the search
strategy. No age limit was used. Language was limited to
Dutch, English, German, and French. We started the
selection in 1977 because we used the Wallace gout criteria
defined in 1977, later called the American College of
Rheumatology (ACR) criteria of the American Rheuma-
tology Association [10]. Additional studies were identified
by searching the reference lists of relevant trials and
reviews. Details of the database searches can be obtained
from the author.
Selection
To select studies for further assessment, two observers (KD
and TT) have independently reviewed the titles, abstracts,
and keywords of every record retrieved. Articles were
selected if the information from title, abstract, or keywords
included gout not caused by another underlying disease and
if the article reported an explicit comparison of male and
female clinical features and a clear description about how
they made the diagnosis of gout. If the information of title,
abstract section, or keywords was unclear, the full article
was retrieved for clarification. If no consensus was reached
about whether to include a study, a third observer (ALJ)
was asked to make a definite decision. Interobserver
agreement for study selection was measured using the
kappa statistic.
The two reviewers assessed the quality of each retrieved
trial independently, using the “Quality criteria list on cohort
studies” (CBO 2003: http://www.cbo.nl/product/richtlijnen/
handleiding_ebro/article20050427141202/articleCBObasic_
view). In this way, we checked whether the study met the
international guideline criteria. We checked the full descrip-
tion of the stated aim of the study, study population, patient
characteristics such as ethnicity, socioeconomic status, and
setting (inpatient or outpatient, general practice), definition
of the study inclusion and exclusion criteria, observation
period, outcome measurements, statistic analysis, and data
presentation. If any of this information was missing, the
article was excluded.
Quality assessment of selected articles
The included full articles were graded and given a quality
score based on the following information: method of
diagnosing gout, female versus male comparisons, the
absolute number and the age of the female patients, and the
type of population and adequate outcome measures (Table 1).
The diagnosis of gout was considered accurate if there was
documentation on urate crystals aspirated from an affected
joint or, failing this, if the clinical characteristics recorded
were sufficient to fulfill the ACR diagnostic criteria of gout
[10]. We also included studies in which the diagnosed gout
was based on a dramatic clinical improvement of the arthritis
as response to a treatment with colchicine.
Results
From MEDLINE, we retrieved 178 original articles. The
two observers (KD, TT) selected 69 articles on title and
abstract (kappa 0.57). From EMBASE and the Cochrane
Library, we retrieved another 20 articles. In the Web of
Science, we searched for articles quoted by the authors of
our top ten articles. No new articles were found. Out of the
89 full articles, we selected 14 original studies with specific
information on sex differences of gout and a clear
description about how they made the diagnosis of gout.
These articles were scored according to the quality criteria
mentioned in Table 1. The maximum score was 5. The
minimum score for inclusion was set on 2.5. Nine articles
were included, and five were excluded (Table 2)[ 11, 15].
Two of the nine articles were conducted in a general
population and seven in a hospital. The age of the male
patients ranged from 53 to 70 years and of the female
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population differed in the studies. In two studies [16, 17],
the diagnosis of gout was made by synovial tap, in one by
using both synovial tap and the ACR criteria [18], in four
by the ACR criteria [19–22], and in two by ACR criteria or
clinical improvement on treatment with colchicines [23].
The best way to classify a patient as having acute gout is to
demonstrate characteristic sodium urate monohydrate crys-
tals in the joint fluid. If the diagnosis is based on colchicine
of ACR criteria, other causes of arthritis were also included
in the studies. Because of this, we reviewed the studies with
crystal-proven gout separately from the studies using the
ACR criteria and the colchicine definition.
The diagnosis of gout based on synovial fluid analysis
Twostudiesarebasedonacrystal-provengout[16, 17]. In the
study of Puig et al., in 89% of the study population, the gout
was crystal-proven (n=40) [18]. Because of the high
percentage, we include this study also in the group
“crystal-proven gout” (Table 3).
Patient characteristics
The age of onset of gout as described in the three studies
was on average 8.1 years later in women, and the duration
of the gout at study entry was significantly higher in men.
Gallerani et al. only studied the influence of the season on
gout attacks and showed a significant peak of gout attacks
in April in male patients, 36% of all the attacks [17]. Most
of the women were postmenopausal at the onset of gout
(86% and 92%).
Considering the use of diuretics, female gout patients
received diuretics significantly more often than male
patients, 57% of the women vs 14% of the men [18] and
83% of the women vs 47% of the men [16]. In the same
studies, men with gout were more likely to drink alcohol
than women, 14% of the women vs 55% of the men [18]
and 10% of the women vs 45% of the men [16]. Puig et al.
also analyzed sex differences in obesity in gout patients and
found no differences between men and women.
Joint location
Puig et al. and Lally et al also described the location of the
arthritis [16, 18]. Men seemed to have a higher prevalence of
podagra at their first attack, 52% of the women vs 57% of
the men [16]. Puig et al. found significantly more tophi in
female gout patients compared to male, 27% in women vs
10% in men [18]. Lally et al. found a higher prevalence of
polyarticular gout in male patients, 56% of the women vs
80% of the men [16]. They found no sex differences in
Prescription Score
Method of proven gout Synovial punction 1.0
ACR criteria 0.5
Diagnosis on specifically defined clinical grounds 0.0
Male/female comparison Specific numbers 1.0
Global, prevalence, incidence 0.5
Number of female patients >26 1.0
11–25 0.5
0–10 0.0
Study population General population 1.0
Primary care 0.5
Hospital 0
Statistics Odds ratio 1.0
Only prevalence/incidence 0.5
Table 1 Score of the quality
criteria
Table 2 Selected studies with a score of less than 2.5 points
Year Score Female Male Age of onset Population Diagnosis
Currie et al. [11] 1978 2.0 168 809 F+9.1 GP ACR
Ter Borg et al. [12] 1987 2.0 22 18 F+3.0 Hosp Colchicine
Cassim et al. [13] 1994 2.0 14 93 F+7.6 Hosp ACR
Kowalec et al. [14] 1978 1.5 9 33 F+1.0 Hosp Punction/ACR
Macfarlane et al. [15] 1985 1.0 9 51 F+21.0 Hosp Punction/ACR
Clin Rheumatol (2010) 29:575–582 577tophaceous gout, but in their study the upper limb seemed to
be more involved in male patients, 44% in women vs 47% in
men [16].
Comorbidities
Finally, Puig et al. and Lally et al. reported the incidence of
“gout-associated comorbidities” as diabetes, hypertension,
and renal insufficiency [16, 18]. In both studies, an
association was found between renal insufficiency and
postmenopausal women, 54% of the women vs 11% of the
men [18] and 30% of the women vs 12% in men [16]. Puig
et al. considered that hypertension was more common in
female than in male gout patients, 78% of the women vs
14% of the men [18]. The sex distribution on diabetes and
gout was equal [18].
Gout according to the ACR criteria or clinical improvement
on colchicine
Six studies did not base the diagnosis on a crystal-proven
gout (Table 4).
Puig [18] Lally [16] Gallerani [17]
Year 1991 1986 1999
Score 3.5 3 2.5
Female 35 23 14
Female% 14 23 7
Male (n) 220 75 196
Study population
Population Hospital Hospital Hospital
Diagnose Syn.tap/ACR Syn.tap Syn.tap
Ethnicity Caucasian Mixed Caucasian
Postmenopausal at onset, n (%) 30 (86) 21(92) –
Average age of women (years) 67 58 68
Average age of men (years) 58 50 56
Age of onset F+12 F+9 F+12
Duration M* M –
Patients characteristics (% women–% men)
Diuretics F* (57–14)* F* (83–47) –
Alcohol M* (14–55) M* (10–45) –
Obesity E ––
Familiar gout – E-
Spring peak –– M**
Recurrence –– –
Location on onset (% women–% men)
Podagra – M (52–57) –
Ankle –– –
Upper limb – M (44–47) –
Fingers –– –
Tophi F* (27–10) E –
Monoarthritis –– –
Polyarthritis M* (56–80) –
Comorbidity (% women–% men)
Hypertension F* (78–14) ––
Dyslipemia –– –
Hypercholesterol. –– –
Chr. heart disease –– –
Peripheral arterial disease –– –
Diabetes E ––
Renal insufficiency F* (54–11) F*(30–12) –
Table 3 Sex differences
according to the three selected
articles with crystal-proven
gout
Syn.tap diagnosed on a synovial
tap, ACR diagnosed according to
the ACR criteria of gout, Post-
menopausal number of post-
menopausal women, Duration
the length of the period since
first gout diagnosis, GP general
practice, F more prevalent in
female, M more prevalent in
men, E equal between men and
women
*p<0.01 (significant);
**p<0.001 (significant)
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The age of onset of gout was on average 9.2 years later in
women (mean age 66 years) compared to men (mean age
54 years), and the duration of the gout at study entry was
significantly higher in men. Most of the women were
postmenopausal at the onset of the gout (66–95%). Three
studies described the use of diuretics [19–21]. In two
studies, female gout patients received diuretics significantly
more often than male patients, 77% in women vs 40% in
men [19] and 72% in women vs 48% in men [20]. Three
studies reported the use of alcohol in gout patients [20–22].
Table 4 Sex differences according to the six selected articles with diagnose gout made by ACR criteria
Harrold [19] Meijers [20] DeSouza [21] Chang [24] Deesomchok [23] Tikly [22]
Year 2004 1986 2005 2004 1989 1998
Score 5 2.5 3.5 2.5 2.5 3.5
Female 1,185 92 27 27 22 21
Female % 19 34 46 21 11 23
Male (n) 4,975 178 31 101 172 69
Study population
Population GP Hospital Hospital GP Hospital Hospital
Diagnose ACR ACR ACR ACR ACR/colchicine ACR
Ethnicity American Blacks Mixed Taiwanese Thais Blacks
Postmenopausal at onset, n (%) –– 19 (66) 22 (81) 18 (82) 20 (95)
Average age of women (years) 70* 61 64 63 59 55
Average age of men (years) 58 51 61 49 52 54
Age of onset F+12** F+10 F+8* F+9* F+8* F+4
Duration –– M –– M
Patients characteristics (% women–% men)
Diuretics F** (77–40) F* (72–48) F ––
Alcohol – M* (2–20) M (7–16) – M* (55–82)
Obesity –– –– M* (92–70)
Familiar gout –– F (40–26) –– –
Spring peak –– – –– –
Recurrence M** –– – – –
Location on onset (% women–% men)
Podagra –– M – M* (23–45) –
Ankle –– – –F* (45–23) –
Upper limb –– F** –– –
Fingers –– – EF * –
Tophi – F (39–26) M (30–48) M* (18–31) F* (34–18) –
Monoarthritis – M** (27–57) –– M –
Polyarthritis – F (63–39) – F (41–24) –
Comorbidity (% women–% men)
Hypertension F** (81–57) E F (81–77) – F (45–39) F* (65–59)
Dyslipemia F** (42–38) E F –– –
Hypercholesterol. E F F –– –
Chr. heart disease F** (25–19) M (26–57) F (25–16) – M( 0 –11) –
Peripheral arterial disease F** (7–4) –– – – –
Diabetes F** (30–17) E M – FE
Renal insufficiency F** (18–10) F* (25–15) F F* (22–12) F –
Syn.tap diagnosed on a synovial tap, ACR diagnosed according to the ACR criteria of gout, Postmenopausal number of postmenopausal women,
Duration the length of the period since first gout diagnosis, GP general practice, F more prevalent in female, M more prevalent in men, E equal
between men and women
*p<0.01 (significant); **p<0.001 (significant)
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alcohol than women, 2% of the women vs 20% of the men
[20], 7% of the women vs 16% of the men [21], and 55% of
the women vs 82% of the men. Tikley et al. found sex
differences in the relation between obesity and gout. In
women, they did not found any relation between the body
mass index (BMI) and gout, but they found a higher
prevalence of gout in men with a BMI>25 (odds ratio 7.8)
[22]. Harrold et al. studied the recurrence of gout attacks
and reported a significantly higher number in men [19].
Gout in the family history was equally distributed between
the sexes [21].
Joint location
The studies of De Souza et al. and Deesomchok et al.
described the location of the arthritis [21, 23]. Men had a
higher prevalence of podagra at their first attack, 23% of
the women vs 45% of the men [23]. During the gout
disease period, the sex differences in the location of the
recurrent attack widened, with an increasingly higher
prevalence of podagra in men [21]. Female patient more
often had other joints involved, such as ankle, fingers, and
upper limb [23]. Polyarticular gout seemed to be more
related to female gout patients, 63% of the women vs 39%
of the men [20] and 41% of the women vs 24% of the men
[23]. The presence of tophi differed in the various studies,
39% of the women vs 26% of the men [20], 30% of the
women vs 48% of the men [21], 18% of the women vs 31%
of the men [24], and 34% of the women vs 18% of the men
[23].
Comorbidities
Fivestudiesreportedtheincidenceofseveral“gout-associated
comorbidities” [19–23]. In four of them, hypertension was
more common in female than in male gout patients, 81% of
the women vs 57% of the men [19], 81% of the women vs
77% of the men [21], 45% of the women vs 39% of the men
[23], and 65% of the women vs 59% of the men [22]. In two
studies, this difference was significant [19, 22]. Five studies
considered diabetes [19–23]. In one study, diabetes was
significantly more prevalent among female than among male
gout patients, 30% of the women vs 17% of the men [19].
The other four were contradicting.
Four studies analyzed the relationship between gout and
cardiovascular heart disease. These results were also
inconsistent, 25% of the women vs 19% of the men [19],
26% of the women vs 57% of the men [20], 25% of the
women vs 16% of the men [21], and 0% of the women vs
11% of the men [23]. Dyslipemia was more common in
women (42% vs 38%) [18–21] and Deesomochok et al. did
not find a sex difference in cerebral vascular accident in
gout patients [23]. In this study, a significantly higher
prevalence of hematologic malignancies was found in
female gout patients, 22% of the women compared to 3%
of the men [23].
Renal insufficiency was studied in five studies, and in
all an association was found with gouty arthritis in
postmenopausal women (in three of them, the association
was significant), especially in those with preexisting joint
disease, 18% of the women vs 10% of the men [19], 25%
of the women vs 15% of the men [20], and 22% of the
women vs 12% of the men [24].
We studied the conclusions of the five excluded studies
and compared these with the nine included papers. No
significant difference in outcome variables was found
between the two groups.
Discussion
We selected nine articles which varied largely in the
characteristics of the study population such as a hospital
population, outpatient department or general population, the
number of postmenopausal women, age, and the ratio of
women and men. Moreover, the method of classifying gout
varied from using the ACR criteria to detecting urate
crystals. These factors influence the clinical features and
make it difficult to compare the results. Therefore, we
divided the studies in one group diagnosed on a synovial
fluid analysis and another group diagnosed on the ACR/
colchicine criteria. Nevertheless, there are great similarities
in results in both groups. Our conclusions are that women
are almost a decade older at the onset of gout arthritis, have
more associated comorbidities such as hypertension and
renal insufficiency, and use less alcohol. Also, the typical
location in the first toe is less frequent in women, and
women are more likely to be taking diuretics. In the crystal-
proven gout group, polyarticular gout tends to be more
prevalent in male while in the ACR group polyarthritis
seems to be related to women.
The difference in age between men and women at the
onset of gout is remarkable. One of the reasons is possibly
the menopause. After the menopause, the incidence of gout
is high compared to the reproductive age [16, 18, 23, 24]
Kim et al. suggested a possible role of 17-beta-estradiol in
the regulation of purine biosynthesis and uric acid
metabolism and lowered serum urate [7]. Also, Hak et al.
found in a recent large prospective study that menopause
increases the risk of gout [25].
Women with gout have more often renal insufficiency
and hypertension, and they more often use diuretics. Is it
because of the older age of female gout patients that they
had a higher percentage of renal dysfunction? Lally et al.
and Bero et al. controlled their study results for age at the
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prevalence of renal insufficiency and diuretic use in female
gout patients [4, 8, 16]. Renal dysfunction reduces urate
excretion, and hyperuricemia has been found to increase
tubular reabsorption of sodium and may thus be predispos-
ing for hypertension and diuretic use. Conversely, hyper-
tension can induce renal dysfunction [26]. Women in
general use diuretics much more frequently than men: a
causal relationship between gout and diuretics is therefore
unclear.
Alcohol increased the risk of gout but plays a less
important role in the development of gout in women.
Alcohol causes hyperuricemia by reducing renal excretion
of urate as a result of increased adine nucleotide turnover.
Female gout patients differ in the location of the gout
arthritis. In women, not only podagra is involved but also
other joints such as fingers and ankle. Therefore, gout
should be considered seriously in the differential diagnosis
of elderly women with an acute (oligo)arthritis, especially
of the ankle. These atypical locations may cause a delay in
the diagnosis because of unfamiliarity of physicians with
the atypical presentation of gout in women. Especially since
a punction of monosodium urate crystals in joint fluid is
seldom used in primary care in the diagnostic procedure.
Another reason for a delay in the diagnosis in women
may be the severity of coexisting diseases because of their
older age compared to men, which overshadows gout.
Studies in which the arthritis location is described in detail
are rare. It seems that gout in female patients has fewer
recurrences.
Harrold et al. performed the first population-based study
with a high number of female patients [19]. In this study,
female gout was more associated with hypertension, dysli-
pemia, chronic heart disease, peripheral arterial disease,
diabetes, and renal insufficiency compared to male patients
with gout. The other studies examining sex differences in
clinical characteristics of gout were very small studies, and
only the study of Chang et al. was population-based [24].
Strengths and limitations of this study
This is, as far as we know, the first systematic review about
clinical features of women with gout arthritis.
This study has some limitations. Firstly, most studies are
based on physician diagnosis by using the ACR criteria or
the response to colchicine, a definition that is subject to
misclassification. The unreliable diagnosis of gout is a
problem. If we had strictly accepted the gout diagnosis on
the basis of urate crystals, only two studies would have
been included [16, 17]. Malik et al. found a positive
predictive value of 66% for ACR criteria compared to the
golden standard crystal identification by synovial tap [27].
So, up to a third of the cases included in these studies might
have false positives. Despite this problem, the results in the
crystal-proven gout studies were quite equal to the studies
using the ACR criteria, and in daily practice the diagnosis
of gouty arthritis is based on clinical grounds without the
use of crystal identification in de synovial fluid.
Another problem is the small number of women in
most studies. Only the study of Harrold et al. performed
a population-based study with a high number of female
patients [19]. In all other included studies, the total
number of included patients, especially women, is much
too low to explore sex differences in gout-related
comorbidities. Besides, most studies are performed in a
clinical setting and depend therefore on presented mor-
bidity. Only the studies of Harrold et al. and Chang et al.
were population-based [15, 18].
Conclusion
This review is a unique study and a start for further
research, in order to realize evidence-based diagnostic
procedures and treatments for female patients with gout
arthritis in general population.
Our systematic review about sex differences in gout
arthritis draws attention to some of the less-known character-
istics of gout. Conclusions must be drawn with great caution
because of the small number of available studies on female
gout,whichhoweverwerecarriedoutindifferentpopulations,
with different criteria and mostly small numbers of women.
We founddifferences in the clinical features of gout arthritis
between men and women. The onset of gout occurs at a later
age in women; they are more likely to have comorbidities such
as hypertension or renal insufficiency, and they use diuretics
more often. Men with gout are more likely to drink alcohol,
and they have a higher prevalence of typical podagra than
female patients. Women may more often have other joints
involved than just one toe, and the gout recurs less often.
More research in general population is necessary to
identify sex differences in clinical features, in order to
avoid a possible delay in diagnosing gout and recognize
patients who are at risk for developing gout. We need
population-based studies with a large number of female
patients. In new research, more attention also have to be
given to the difference in first recurrent episodes of gout.
Do clinical features differ in these two groups?
Because gout is a rare disease in women and it can have
an unusual way of manifesting itself, it is very important to
recognize the symptoms. Physicians should consider gout
arthritis especially in elderly female patients with hyper-
tension, diuretic use, and renal insufficiency and arthritis in
one or more joints. It is easy to overlook or pay little
attention to the chronic joint problems because the female
patients are older and frequently have chronic diseases. The
Clin Rheumatol (2010) 29:575–582 581recognition of gout even with an atypical course is
important because there are therapeutic strategies to reduce
recurring unnecessary pain and complications like tophi
deformities, nephropathy, and joint destruction.
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